mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.02 |
mRNA |
CID-5951923 |
CTRPv2 |
pan-cancer |
AAC |
-0.09 |
0.02 |
mRNA |
JQ-1:UNC0638 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |
mRNA |
clofarabine |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.02 |
mRNA |
erlotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |
mRNA |
canertinib |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.03 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.03 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.03 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
-0.085 |
0.03 |